Company Overview
| Stock Name | Tycoon Group |
|---|---|
| Stock Code | 03390 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 提供多種中成藥、保健、皮膚護理、個人護理及其他健康護理產品的供應商,主要於香港銷售及分銷相關產品,並通過分銷業務及零售業務(線上及線下)向客戶及消費者銷售。 |
| Listing Date | 2020-04-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港新界沙田坳背灣街38-40號華衛工貿中心8樓14室 |
| Business Address (Hong Kong) | 香港新界沙田坳背灣街38-40號華衛工貿中心8樓14室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.tycoongroup.com.hk |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.49 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.01 / shares |
| Offer Period | 2020-03-30 to 2020-04-03 |
| Global Offering Shares | 192,420,000 shares |
| HK Public Offer Shares (Initial) | 19,242,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 173,178,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 800,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 27.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 286,705,800 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 232.6M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +4076% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 1,192,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | 992,683,000港元 |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約54.5百萬港元 |
| Period-End Cash Balance | 50.4百萬港元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
HKD
Income Statement
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Revenue | 366,478 | 693,326 | 700,755 |
| Cost of sales | -257,987 | -483,027 | -509,614 |
| Gross profit | 108,491 | 210,299 | 191,141 |
| Other income and gains, net | 17 | 18 | 397 |
| Selling and distribution expenses | -15,409 | -47,729 | -62,295 |
| Administrative expenses | -12,547 | -33,598 | -54,894 |
| Net finance costs | -2,677 | -11,714 | -5,989 |
| Profit before tax | 76,795 | 123,679 | 68,360 |
| Income tax expense | -12,869 | -22,779 | -13,844 |
| Profit for the year | 63,926 | 100,900 | 54,516 |
| Profit attributable to owners | 63,938 | 100,829 | 54,409 |
Balance Sheet
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Cash and cash equivalents | 21,862 | 59,196 | 50,437 |
| Trade and bills receivables | 90,005 | 145,402 | 117,161 |
| Inventories | 25,051 | 73,891 | 84,069 |
| Total current assets | 215,014 | 296,968 | 285,475 |
| Total assets | 242,755 | 378,500 | 366,364 |
| Total current liabilities | 67,198 | 255,073 | 240,052 |
| Total liabilities | 119,633 | 264,549 | 248,004 |
| Total equity | 123,122 | 113,951 | 118,360 |
| Equity attributable to owners | 123,122 | 113,951 | 118,360 |
| Interest-bearing borrowings | 29,670 | 126,524 | 151,120 |
Cash Flow Statement
| Item | 2017 | 2018 | 2019 |
|---|---|---|---|
| Net cash from operating activities | 6,412 | 37,939 | 77,184 |
| Net cash from investing activities | -58,044 | -55,807 | 2,176 |
| Net cash from financing activities | 68,449 | 55,274 | -88,011 |
| Net increase in cash | 16,817 | 37,406 | -8,651 |
| Depreciation of PP&E | 626 | 2,158 | 4,135 |
| Depreciation of right-of-use assets | 2,564 | 5,164 | 7,712 |
| Purchase of PP&E | -19,019 | -34,211 | -5,225 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 0.96 |
|---|---|
| First Day Open | HK$ 1.28 |
| First Day Change | -35.57% |
| First Day Volume | 42646000.0 |
| First Day Turnover | 48608300.0 |
| Use of Proceeds | 1、約30.0%(或67.7百萬港元)預期用于進一步發展我們的供應鏈及零售管理;
2、約15.0%(或33.9百萬港元)預期用于進一步投資于我們的品牌管理,以提高大眾對本集團及產品的認識;
3、約45.0%(或101.6百萬港元)預期用于償還我們部分銀行借款;
4、約10.0%(或22.5百萬港元)預期用作一般營運資金用途。 |
Underwriting Syndicate
Sole Sponsor (1)
SHENWAN HONGYUAN CAPITAL (H.K.) LIMITED CE ABC209
Joint Bookrunners (6)
Joint Lead Managers (10)
SHENWAN HONGYUAN CAPITAL (H.K.) LIMITED CE ABC209
东吴证券国际经纪有限公司 CE AYA587
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
SPDB International Capital Limited CE BFZ375
YUE XIU SECURITIES COMPANY LIMITED CE ABQ722
GLAM Capital Limited CE BNR298
Livermore Holdings Limited CE BJN764
VALUABLE CAPITAL LIMITED CE AUL711
TradeMaster Securities (Hong Kong) Limited CE BHJ844
Golden K2 Securities Limited CE BIJ477
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Jacobson Group Treasury Limited | 79,998,100 HKD | — | 27.90% | — | 6 months | 2020-10-15 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 王嘉俊 | — |
| Company Secretary | 張玉存 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Tycoon Empire及王先生為控股股東,緊隨全球發售(假設超額配股權不獲行使)及資本化發行完成後,Tycoon Empire實益擁有約56.01%權益,王先生被視為擁有約56.01%權益;華潤醫藥透過IPO前投資者A持有約18.99%權益。 |
|---|




